Om läkemedel, life science och sjukvård ur olika vinklar med experter från Lif – de forskande läkemedelsföretagen och deras gäster.

Läkemedelsbranschen
Claim This Podcastby Lif
Podcast Overview
Om läkemedel, life science och sjukvård ur olika vinklar med experter från Lif – de forskande läkemedelsföretagen och deras gäster.
Language
🇸🇪
Publishing Since
1/20/2022
Reach the team behind Läkemedelsbranschen
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes

June 22, 2026
Lifs valpodd - Avsnitt 5
Nils Seye Larsen (MP) och Christian Carlsson (KD) är sista politikerparet att mötas i Lifs valpodd. De diskuterar bland annat vaccinationsprogram, innovationsklimatet för life science och varför en patient i Sverige får vänta längre än en patient i andra länder på nya läkemedel.

June 22, 2026
Lifs valpodd - Avsnitt 5 (video)
Nils Seye Larsen (MP) och Christian Carlsson (KD) är sista politikerparet att mötas i Lifs valpodd. De diskuterar bland annat vaccinationsprogram, innovationsklimatet för life science och varför en patient i Sverige får vänta längre än en patient i andra länder på nya läkemedel.

June 17, 2026
Lifs valpodd - Avsnitt 4
Socialminister Jakob Forssmed, Kristdemokraterna, kommer till Lifs valpodd och diskuterar bland annat läkemedssystemets svagheter och framtid, östrogenplåster och tillgång till läkemedel i kristid. Poddvärdar är Anna Charlotta Johansson, chef för kommunikation och partnerskap, och Jenni Nordborg, chef för strategi och samhällskontakter på Lif – de forskande läkemedelsföretagen.
63 total episodes available
Recent guests on Läkemedelsbranschen
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Pernilla Becker
Guest
Karolina Antonov
Guest
Lina Nordquist
Guest
Anders W Jonsson
Guest
Åsa Derolf
Guest
Oskar Ahlberg
Guest
Martin Henriksson
Guest
Johan Brun
Guest
Anders Blanck
Guest
Göran Stiernstedt
Guest
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Läkemedelsbranschen
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Läkemedelsbranschen?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.



